GSA INVEST ApS: Financial statements 2022
CVR: 75358210
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
GSA INVEST ApS (CVR 75358210) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 1,723,000 and a net result of DKK 178,038,000 compared with DKK 75,089,000 the year before. That is a decrease of 25.3% compared with the year before. The profit margin was 10,333%. Equity in the 2022 report amounted to DKK 2,189,497,000. The solvency ratio was 90.2%. The company had 20 employees in the financial year.
- Revenue
- DKK 1,723,000
- Gross Profit
- DKK 607,000
- Profit/Loss
- DKK 178,038,000
- Equity
- DKK 2,189,497,000
- Total Assets
- DKK 2,428,305,000
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 1.7M | 607K | 178M | 2.2B | 20 |
| 2021 | 2.3M | 1.2M | 75.1M | 2B | 18 |
| 2020 | 2.1M | 963K | 62M | 1.9B | 20 |
| 2019 | 2.2M | 1.2M | 34.5M | 1.8B | 22 |
| 2018 | 3.6M | 2.2M | 51.7M | 1.8B | 21 |
Official annual report
Keep an eye on GSA INVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GSA INVEST ApS has published its annual report for 2021. Revenue came to DKK 2,306,000, and the net result was DKK 75,089,000.
About GSA INVEST ApS
GSA INVEST ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 1984. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named WIDEX HOLDING ApS and WIDEX ApS. The management consists of Lars Nørgaard. The board consists of Anders Steen Westermann (chair), Jan Tøpholm and Søren Erik Westermann. The company is owned by T&W Medical A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -1,043,000 and a net result of DKK 216,304,000 compared with DKK 85,656,000 the year before. Equity in the 2025 report amounted to DKK 530,132,000.
